Biggest insider buyers of 2024
The insiders who spent the most buying their own company's shares on the open market in 2024.
Covers 2024; updated October 31, 2026.
| # | Insider | Company | Trades | Value |
|---|---|---|---|---|
| 1 | Warren E. Buffett | Liberty Media Corporation, Occidental Petroleum Corporation, SiriusXM Holdings Inc., VeriSign Inc. | 64 | $1,723,001,725 |
| 2 | Control Empresarial de Capitales S.A. de C.V. | PBF Energy Inc., ProKidney Corp., Talos Energy Inc. | 95 | $927,371,738 |
| 3 | Ariel Emanuel | TKO Group Holdings Inc. | 19 | $271,777,426 |
| 4 | Egon Durban | TKO Group Holdings Inc. | 19 | $271,777,426 |
| 5 | Peter Kolchinsky | Artiva Biotherapeutics Inc., Boundless Bio Inc., Climb Bio Inc., Janux Therapeutics Inc., PepGen Inc. | 8 | $235,865,602 |
| 6 | Farhad Nanji | RXO Inc. | 1 | $207,492,230 |
| 7 | Weinstein Boaz | Adams Natural Resources Fund Inc., AllianceBernstein National Municipal Income Fund Inc, BlackRock Capital Allocation Term Trust, BlackRock ESG Capital Allocation Term Trust, BlackRock Health Sciences Term Trust, BlackRock Technology and Private Equity Term Trust, Blackrock MuniYield Pennsylvania Quality Fund, Destra Multi-Alternative Fund, Ellsworth Growth and Income Fund Ltd., Federated Hermes Premier Municipal Income Fund, GAMCO Natural Resources Gold & Income Trust, Invesco Pennsylvania Value Municipal Income Trust, Invesco Trust for Investment Grade New York Municipals, NYLIM CBRE Global Infrastructure Megatrends Term Fund, Nuveen Core Plus Impact Fund, PIMCO Dynamic Income Strategy Fund, The Gabelli Healthcare & Wellness Trust, abrdn Global Infrastructure Income Fund, abrdn Life Sciences Investors | 252 | $149,289,517 |
| 8 | Jones Jerral W. | Comstock Resources Inc. | 4 | $134,948,158 |
| 9 | APMH Invest A/S | Noble Corporation plc A | 17 | $121,730,205 |
| 10 | COLL WAYNE M | Precision Optics Corporation Inc. | 1 | $107,905,271 |
| 11 | Rakesh Gangwal | Southwest Airlines Company | 193 | $106,703,388 |
| 12 | Jay C. Hoag | Zillow Group Inc. | 15 | $99,966,391 |
| 13 | Handy Steve | Giftify Inc. | 2 | $92,861,092 |
| 14 | Roelof Botha | Block Inc., Maplebear Inc. | 8 | $82,654,932 |
| 15 | Mario J. Gabelli | Atlanta Braves Holdings Inc., GAMCO Natural Resources Gold & Income Trust, Gabelli Dividend & Income Trust, The Gabelli Equity Trust Inc., The Gabelli Healthcare & Wellness Trust | 35 | $78,927,640 |
| 16 | Rajeev M. Shah | Jade Biosciences Inc., Septerna Inc. | 3 | $76,609,944 |
| 17 | Matthew T. Moroun | Pamt Corp | 1 | $74,059,866 |
| 18 | John F. Barry | Prospect Capital Corporation | 21 | $69,482,384 |
| 19 | Bihua Chen | BioAge Labs Inc., BridgeBio Oncology Therapeutics Inc., Corbus Pharmaceuticals Holdings Inc. | 28 | $64,539,500 |
| 20 | Ravi Gupta | Maplebear Inc. | 8 | $61,768,659 |
| 21 | Christopher Binyon Sarofim | Sable Offshore Corp. | 2 | $60,000,000 |
| 22 | Thilo Schroeder | Revolution Medicines Inc. | 2 | $59,999,962 |
| 23 | Pablo G. Legorreta | ProKidney Corp. | 1 | $54,735,340 |
| 24 | Wesley R. Edens | New Fortress Energy Inc. | 1 | $49,999,993 |
| 25 | CLARK JAMES H | Ibotta Inc. | 1 | $49,999,928 |
| 26 | Lorenzo J. Fertitta | Red Rock Resorts Inc. | 5 | $47,211,640 |
| 27 | Wayne P. Rothbaum | Iovance Biotherapeutics Inc. | 1 | $45,750,000 |
| 28 | TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA | Nuveen Churchill Direct Lending Corp. | 2 | $45,708,322 |
| 29 | Charles W. Ergen | EchoStar Corporation | 1 | $43,499,994 |
| 30 | Charles K. Cohn | Nerdy Inc. | 37 | $40,232,980 |
| 31 | Jonathan H. Cohen | Oxford Lane Capital Corp. | 2 | $40,038,800 |
| 32 | Saul B. Rosenthal | Oxford Lane Capital Corp. | 3 | $40,038,800 |
| 33 | James B. Tananbaum | Alumis Inc. | 2 | $40,000,000 |
| 34 | Keith A. Meister | Vestis Corporation | 4 | $35,782,678 |
| 35 | John Edward Miller | NextPlat Corp | 1 | $35,750,000 |
| 36 | James C. Flores | Sable Offshore Corp. | 5 | $33,574,055 |
| 37 | Frederik Wilhelm Mohn | Transocean Ltd (Switzerland) | 4 | $33,565,000 |
| 38 | Sam Levinson | Five Point Holdings LLC, Sonida Senior Living Inc. | 4 | $32,091,532 |
| 39 | James Healy | ArriVent BioPharma Inc., BioAge Labs Inc., Rapport Therapeutics Inc. | 23 | $30,579,673 |
| 40 | Robert Nelsen | Prime Medicine Inc., Sana Biotechnology Inc. | 4 | $29,999,996 |
| 41 | Dirk Kersten | Dyne Therapeutics Inc. | 2 | $29,999,988 |
| 42 | Carl L. Gordon | Adicet Bio Inc., ArriVent BioPharma Inc., MBX Biosciences Inc. | 7 | $27,499,992 |
| 43 | Neil Mehta | Coupang Inc. | 5 | $27,271,679 |
| 44 | Stellantis N.V. | Archer Aviation Inc. | 5 | $25,616,177 |
| 45 | Moran Colin T. | Appian Corporation | 12 | $25,084,825 |
| 46 | Gregg Hymowitz | flyExclusive Inc. | 1 | $25,000,000 |
| 47 | Yong-Jun Huh | Artiva Biotherapeutics Inc. | 2 | $24,999,984 |
| 48 | Timothy A. Springer | Cartesian Therapeutics Inc., Tectonic Therapeutic Inc. | 39 | $24,940,701 |
| 49 | Paul J. Fribourg | The Estee Lauder Companies Inc. | 10 | $24,924,493 |
| 50 | Seemab Muhammad Asif | The Children's Place Inc. | 6 | $24,749,525 |
| 51 | Joshua Kushner | Oscar Health Inc. | 7 | $23,063,788 |
| 52 | Vijay Satyanand Pande | BioAge Labs Inc. | 4 | $20,529,019 |
| 53 | Daniel Patrick Gibson | Impinj Inc. | 1 | $20,000,003 |
| 54 | Simeon George | Nkarta Inc. | 2 | $20,000,000 |
| 55 | Randal J. Kirk | Precigen Inc. | 1 | $19,999,999 |
| 56 | Keith A. Hutton | TXO Partners L.P. | 4 | $19,465,000 |
| 57 | Sardar Biglari | Biglari Holdings Inc. | 50 | $18,848,701 |
| 58 | Wilks Dan H. | ProFrac Holding Corp. | 12 | $18,064,728 |
| 59 | Lester B. Knight | Aon plc | 8 | $17,864,616 |
| 60 | Michael J. Angelakis | Clarivate Plc | 3 | $17,863,350 |
| 61 | Henry Schuck | ZoomInfo Technologies Inc | 2 | $17,783,125 |
| 62 | Lawande Mahesh | Precision Optics Corporation Inc. | 1 | $17,248,850 |
| 63 | Joseph Norman Forkey | Precision Optics Corporation Inc. | 1 | $17,228,869 |
| 64 | SOSIN CLIFFORD | Cardlytics Inc. | 6 | $16,796,539 |
| 65 | James Monroe III | Globalstar Inc. | 12 | $16,783,506 |
| 66 | Jason Raleigh Nunn | Zenas BioPharma Inc. | 2 | $14,999,984 |
| 67 | Steven B. Klinsky | New Mountain Finance Corporation | 48 | $14,689,309 |
| 68 | Patrick G. Enright | BioAge Labs Inc., Zenas BioPharma Inc. | 2 | $14,680,000 |
| 69 | Michael David Braner | American Public Education Inc., Motorcar Parts of America Inc. | 31 | $14,180,967 |
| 70 | Erez Chimovits | Upstream Bio Inc. | 2 | $14,025,000 |
| 71 | Frank J. Fertitta III | Red Rock Resorts Inc. | 8 | $14,008,360 |
| 72 | William Wallace McMullen | Mach Natural Resources LP | 6 | $13,753,289 |
| 73 | Paul B. Manning | Candel Therapeutics Inc., Liquidia Corporation, Taysha Gene Therapies Inc. | 4 | $13,499,993 |
| 74 | Kristina Burow | Boundless Bio Inc., Sana Biotechnology Inc. | 5 | $13,199,996 |
| 75 | John W. Childs | Biohaven Ltd. | 8 | $13,053,804 |
| 76 | David Golub | Golub Capital BDC Inc. | 18 | $12,690,308 |
| 77 | Neil P. Simpkins | Gates Industrial Corporation Ltd. | 1 | $12,200,000 |
| 78 | John D. Diekman | Skye Bioscience Inc. | 1 | $12,026,031 |
| 79 | Tiba Aynechi | MBX Biosciences Inc. | 1 | $12,000,000 |
| 80 | Steven T. Mnuchin | Starz Entertainment Corp. | 7 | $11,596,672 |
| 81 | Jared Isaacman | Shift4 Payments Inc. | 4 | $11,329,623 |
| 82 | Lawrence E. Golub | Golub Capital BDC Inc. | 17 | $11,267,678 |
| 83 | Phillip Md Et Al Frost | OPKO Health Inc. | 21 | $10,881,250 |
| 84 | Kevin Tang | Aurinia Pharmaceuticals Inc | 3 | $10,822,000 |
| 85 | JOHNSON CHARLES B | Franklin Templeton Inc. | 4 | $10,681,000 |
| 86 | Ali John Mirshekari | Sensata Technologies Holding plc | 2 | $10,636,565 |
| 87 | Amnon Shashua | Mobileye Global Inc. | 2 | $10,431,978 |
| 88 | Patrick J. Heron | Arcutis Biotherapeutics Inc., MBX Biosciences Inc., Mirum Pharmaceuticals Inc. | 4 | $10,213,858 |
| 89 | Rory Wallace | Barnes & Noble Education Inc | 1 | $10,124,039 |
| 90 | Glenn H. Hutchins | CoreWeave Inc. | 2 | $10,000,660 |
| 91 | David Goeddel V | Tenaya Therapeutics Inc. | 1 | $9,999,999 |
| 92 | Michael Doak | TWFG Inc. | 1 | $9,999,995 |
| 93 | Gary G. Friedman | RH | 6 | $9,999,994 |
| 94 | Jonathan Z. Buba | America's Car-Mart Inc | 1 | $9,999,994 |
| 95 | Andrew J. Schwab | CAMP4 Therapeutics Corporation | 1 | $9,999,990 |
| 96 | Amir Nashat | CAMP4 Therapeutics Corporation | 1 | $9,999,990 |
| 97 | Bicknell Martin C | Palmer Square Capital BDC Inc. | 1 | $9,999,988 |
| 98 | Michael L. Speiser | Snowflake Inc. | 1 | $9,989,058 |
| 99 | John C. Malone | Liberty Latin America Ltd. | 6 | $9,955,334 |
| 100 | Leonard Braden Michael | AN2 Therapeutics Inc., Aclaris Therapeutics Inc., OnKure Therapeutics Inc., Tectonic Therapeutic Inc. | 36 | $9,848,402 |
How this ranking is built
Open-market purchases (transaction code P) reported on SEC Forms 4 and 5 by directors, officers and 10% owners, dated in the year, valued at shares × reported price and summed per insider (by SEC CIK). Individuals only: funds, trusts and holding companies that report as 10% owners are left out, since several of them often report the same shares on one joint filing. Amended filings are not counted; grants, option exercises and awards are left out. Trades whose filed price cannot be right — one line worth over $1 billion, or a price more than 10 times the company's median that year — are left out too: filers sometimes type the total into the price field.
Free to cite with a link to this page. Spotted an error? Tell us.